Tuesday, March 21, 2023
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.
Professor
Director of Dermatology
Department of Experimental, Diagnostic and Specialty Medicine
University of Bologna
Bologna, Italy
Director
Trichology Unit
Ramón y Cajal University Hospital
Trichology and Hair Transplant Unit
Pedro Jaén Group Clinic
Associate Professor of Dermatology
University of Alcalá
Madrid, Spain
Professor
Department of Dermatology, Venereology and Allergology
Vice Director
Clinical Research Center for Hair and Skin Science
Charité-Universitätsmedizin Berlin
Berlin, Germany
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Non-US Physicians - maximum of 0.75 CPD
This activity is intended for a global audience of dermatologists, primary care practitioners, and clinical immunologists outside of the United States.
The goal of this activity is for learners to be better able to understand the impact of alopecia areata (AA) on patients’ lives and unmet needs related to the lack of effective therapies, to review and contextualize key clinical data on emerging treatments for AA, specifically Janus kinase (JAK) inhibitors, and to explore which patients would benefit from these new therapies.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.
Professor
Director of Dermatology
Department of Experimental, Diagnostic and Specialty Medicine
University of Bologna
Bologna, Italy
Director
Trichology Unit
Ramón y Cajal University Hospital
Trichology and Hair Transplant Unit
Pedro Jaén Group Clinic
Associate Professor of Dermatology
University of Alcalá
Madrid, Spain
Professor
Department of Dermatology, Venereology and Allergology
Vice Director
Clinical Research Center for Hair and Skin Science
Charité-Universitätsmedizin Berlin
Berlin, Germany
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.75 continuing professional development credits (CPD).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information about your
eligibility to claim credit, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must
complete the activity online during the credit eligibility period that is noted on the title page.
Follow these steps to claim a credit certificate for completing this activity:
We encourage you to complete an Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CPD Released: 9/27/2022
Valid for credit through: 9/27/2023
processing....
Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.
